IGC Pharma, Inc. Annual Amortization of Intangible Assets in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
IGC Pharma, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2019 to 2023.
  • IGC Pharma, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $20K, a 11.1% increase year-over-year.
  • IGC Pharma, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $78K, a 13% increase year-over-year.
  • IGC Pharma, Inc. annual Amortization of Intangible Assets for 2023 was $74K, a 29.8% increase from 2022.
  • IGC Pharma, Inc. annual Amortization of Intangible Assets for 2022 was $57K, a 138% increase from 2021.
  • IGC Pharma, Inc. annual Amortization of Intangible Assets for 2021 was $24K, a 50% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $74K +$17K +29.8% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 $57K +$33K +138% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 $24K +$8K +50% Apr 1, 2021 Mar 31, 2022 10-K 2023-07-07
2020 $16K +$6K +60% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $10K Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.